Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes
Alessandra Gambineri(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Renato Pasquali(University of Bologna), Paola Altieri(Ospedale Policlinico San Martino), Lamberto Manzoli(University of Ferrara), Laura Patton(Unknown), Uberto Pagotto(Azienda USL di Bologna), Carmine Pizzi(Azienda USL di Bologna)
Cited by 225
Related Papers
Heart Rate Variability Today
|Progress in Cardiovascular Diseases|2012|457
An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
|Hormone Research in Paediatrics|2017|451
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Endothelial Function Predicts Future Development of Coronary Artery Disease
|Circulation|2004|348
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292